INSIGHTS ON UPSTREAM MANUFACTURING

UPSTREAM MANUFACTURING SOLUTIONS

  • Evaluate your clones, strains, and viral constructs in our bioreactors with flexible scale out.

    Benefits

    Select the best clone by evaluating larger experimental cohorts

    Make the most informed, data-driven selection by leveraging our fleet of 250mL and 5L Culture bioreactors to screen your clones, strains and viral constructs.

    Defer your capital equipment spend

    Evaluate your clones, strains and viral constructs without the need for new capital equipment.

    Transparent, real-time data provided by a team of experts

    Painless technology transfer with live data relayed via our cloud-connected systems. We have >95% success rate with >22,000 runs successfully executed.

  • Gain access to Culture bioreactors when you need rapid overflow experimental capacity.

    Benefits

    Progress studies faster

    Run overflow projects and conduct parallel experiments with Culture to reduce time and alleviate bottlenecks.

    Stay agile in your capacity planning

    Scale your workload at Culture according to your current needs. Respond rapidly to surging demands.

    Eliminate your capital equipment spend

    Leverage Culture’s facility quickly to avoid building out lab space, spending capital on equipment, and hiring specialized staff.

  • Assess your process in scale-down bioreactors that allow for increased model curvature and variables in your process DOEs.

  • Discover a cutting-edge approach that enables you to screen for glycans at every stage of CLD and streamline your workflow.

  • Discover an assay that leverages the power of whole genome sequencing and expert bioinformatics to deliver a faster, all-in-one solution for a comprehensive testing package.